Skip to main content
. 2019 May 2;36(6):1291–1303. doi: 10.1007/s12325-019-00957-y

Table 2.

Parameters of diabetes control

Intervention group Control group p value
HbA1c % (mean ± SD) n = 160 n = 162
 Baseline 7.9 ± 1.1 7.7 ± 0.8 0.11c
 6 months 7.4 ± 1.0**** 7.5 ± 0.8*** 0.212c
 12 months 7.3 ± 0.9**** 7.6 ± 1.0** 0.067c
Patients with HbA1c < 7%, n (%)
 Baseline 4/188 (2.1) 0/189 (0) 0.1230a
 6 months 57/160 (35.6) 32/163 (19.6) 0.0013b
LDL-c mg/dl (mean ± SD) n = 78 n = 74
 Baseline 110 ± 40 120 ± 60 0.0840c
 6 months 100 ± 30 120 ± 50 0.0306c
 12 months 110 ± 40 110 ± 50 0.3665c
Systolic blood pressure, mmHg (mean ± SD) n = 119 n = 115
 Baseline 134.4 ± 11.6 137.0 ± 11.6 0.0884c
 6 months 133.7 ± 10.1 136.8 ± 9.6 0.0160c
 12 months 134.9 ± 10 136.9 ± 9.8 0.1378c
Diastolic blood pressure, mmHg (mean ± SD) n = 118 n = 113
 Baseline 78.5 ± 8.7 79.9 ± 8.2 0.2124c
 6 months 78.7 ± 8.4 81.1 ± 9.5 0.0405c
 12 months 79.8 ± 8.3 79.9 ± 7.8 0.9315c

Within-group comparisons versus baseline performed using the Student’s paired test: **p < 0.01, ***p < 0.001, ****p < 0.0001

n number of patients for which data were available. Missing data were excluded from the analysis

aBetween-group comparisons of percentages performed using Fisher’s test

bBetween-group comparisons of percentages performed using the chi-squared test

cBetween-group comparisons of means: analysis of variance (ANOVA Fisher-Snedecor)